Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk

Journal of Nutrition

Volumn 139, Issue 5, 2009, Pages 1008-1012

  Ko, Kwang Pil ^a   Park, Sue K ^a,b   Cho, Lisa Y ^a   Gwack, Jin ^a   Yang, Jae Jeong ^a   Shin, Aesun ^c   Kim, Cheong Sik ^d   Kim, Yeonju ^c   Kang, Daehee ^a,b   Chang, Soung Hoon ^e   Shin, Hai Rim ^c   Yoo, Keun Young ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c National Cancer Center   (South Korea)

^d Korea Centers for Disease Control and Prevention   (South Korea)

^e Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; BACTERIUM ANTIBODY;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOYBEAN; STOMACH CANCER; BLOOD; COHORT ANALYSIS; DIET; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; KOREA; MICROBIOLOGY; PHYTOTHERAPY; PROSPECTIVE STUDY; RISK FACTOR; STOMACH TUMOR;

GLYCINE MAX; HELICOBACTER PYLORI;

ANTIBODIES, BACTERIAL; COHORT STUDIES; DIET; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER PYLORI; INTERLEUKIN-10; KOREA; PHYTOTHERAPY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SOY FOODS; SOYBEANS; STOMACH NEOPLASMS;

EID: 65349167201     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.101865     Document Type: Article

References (56)

1. Parkin DM. International variation. Oncogene. 2004;23:6329-40.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
3. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321-33.
4. Sipponen P. Gastric cancer: pathogenesis, risks, and prevention. J Gastro-enterol. 2002;37 Suppl 13:39-44.
5. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 1994.
6. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28-37.
7. Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer. 2005;92:1273-5.
8. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, Jun JK, Bae J, Park SK, Hong YC, et al. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer. 2006;95:639-41.
9. Kim Y, Shin A, Gwack J, Jun JK, Park SK, Kang D, Shin HR, Chang SH, Yoo KY. [Cigarette smoking and gastric cancer risk in a community-based cohort study in Korea]. J Prev Med Public Health. 2007;40:467-74.
10. Jun JK, Gwack J, Park SK, Choi YH, Kim Y, Shin A, Chang SH, Shin HR, Yoo KY. [Fasting serum glucose level and gastric cancer risk in a nested case-control study]. J Prev Med Public Health. 2006;39:493-8.
11. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689-701.
12. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007;10:75-83.
13. El-Omar EM, Chow WH, Rabkin CS. Gastric cancer and H. pylori: host genetics open the way. Gastroenterology. 2001;121:1002-4.
14. Merchant JL. Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology. 2005;129:1079-82.
15. Wang M, Furuta T, Takashima M, Futami H, Shirai N, Hanai H, Kaneko E. Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J Gastroenterol. 1999;34 Suppl 11:10-7.
16. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997;41:442-51.
17. Wu AH, Yang D, Pike MC. A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev. 2000;9:1051-8.
18. Nagata C, Takatsuka N, Kawakami N, Shimizu H. A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer. 2002;87:31-6.
19. Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, Kang D, Lee DH. Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asian Pac J Cancer Prev. 2002;3:85-92.
20. Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, Graham DY, Yamaoka Y. New serological assay for detection of putative Helico-bacter pylori virulence factors. J Clin Microbiol. 2002;40:4753-6.
21. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol. 2001;166:7456-61.
22. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1-8.
23. Sutton P, Kolesnikow T, Danon S, Wilson J, Lee A. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun. 2000;68:4802-4.
24. Bodger K, Wyatt JI, Heatley RV. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut. 1997;40:739-44.
25. Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol. 2007;22:1443-9.
26. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT. Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer. 2008;44:2648-54.
27. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193-201.
28. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104:617-23.
29. Inoue M, Tajima K, Kobayashi S, Suzuki T, Matsuura A, Nakamura T, Shirai M, Nakamura S, Inuzuka K, et al. Protective factor against progression from atrophic gastritis to gastric cancer: data from a cohort study in Japan. Int J Cancer. 1996;66:309-14.
30. Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer. 2002;97:531-5.
31. Ito LS, Inoue M, Tajima K, Yamamura Y, Kodera Y, Hirose K, Takezaki T, Hamajima N, Kuroishi T, et al. Dietary factors and the risk of gastric cancer among Japanese women: a comparison between the differentiated and non-differentiated subtypes. Ann Epidemiol. 2003;13:24-31.
32. Ahn YO. Diet and stomach cancer in Korea. Int J Cancer. 1997;10:7-9.
33. Galanis DJ, Kolonel LN, Lee J, Nomura A. Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. Int J Epidemiol. 1998;27:173-80.
34. Mansour A, McCarthy B, Schwander SK, Chang V, Kotenko S, Donepudi S, Lee J, Raveche E. Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion. Cell Cycle. 2004;3:1597-605.
35. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA. Daidzein and genistein content of fruits and nuts. J Nutr Biochem. 2000;11:326-31.
36. Sakai T, Kogiso M. Soy isoflavones and immunity. J Med Invest. 2008;55:167-73.
37. Zhang R, Li Y, Wang W. Enhancement of immune function in mice fed high doses of soy daidzein. Nutr Cancer. 1997;29:24-8.
38. Verdrengh M, Collins LV, Bergin P, Tarkowski A. Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect. 2004;6:86-92.
39. Dahle MK, Overland G, Myhre AE, Stuestol JF, Hartung T, Krohn CD, Mathiesen O, Wang JE, Aasen AO. The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun. 2004;72:5704-11.
40. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut. 2004;53:1082-9.
41. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-801.
42. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005;54:330-5.
43. Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14:2487-93.
44. Lee WP, Tai DI, Lan KH, Li AF, Hsu HC, Lin EJ, Lin YP, Sheu ML, Li CP, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopa- thology in Chinese population. Clin Cancer Res. 2005;11:6431-41.
45. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcino-genesis. 2005;26:631-6.
46. Canedo P, Castanheira-Vale AJ, Lunet N, Pereira F, Figueiredo C, Gioia-Patricola L, Canzian F, Moreira H, Suriano G, et al. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev. 2008;17:28-32.
47. KÅmangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, Pietinen P, Dawsey SM, Albanes D, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117-25.
48. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 1998;42:227-34.
49. KAmangar F, Cheng C, Abnet CC, Rabkin CS. Interleukin-1B polymorphisms and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1920-8.
50. Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, Rhee JC, Song SY, Sohn TS. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol. 2004;39:429-33.
51. Vercelli D, Jabara HH, Lauener RP, Geha RS. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol. 1990;144:570-3.
52. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998;114:482-92.
53. Togawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, Tajima K, Hamajima N. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter. 2005;10:172-8.
54. Savage SA, Abnet CC, Haque K, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR, Chanock SJ. Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. Cancer Epidemiol Biomarkers Prev. 2004;13:1547-9.
55. Lai KC, Chen WC, Jeng LB, Li SY, Chou MC, Tsai FJ. Association of genetic polymorphisms of MK, IL-4, p16, p21, p53 genes and human gastric cancer in Taiwan. Eur J Surg Oncol. 2005;31:1135-40.
56. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ. 2004;150:301-10.